Fábio Guilherme Campos, Division of Colorectal Surgery, Department of Gastroenterology, Hospital das Clínicas, University of São Paulo, São Paulo, SP 01411000, Brazil.
World J Gastroenterol. 2017 Jul 28;23(28):5041-5044. doi: 10.3748/wjg.v23.i28.5041.
Sporadic colorectal cancer (CRC) is traditionally diagnosed after the sixth decade of life, and current recommendations for surveillance include only patients older than 50 years of age. However, an increasing incidence of CRC in patients less than 40 years of age has been reported. This occurrence has been attributed to different molecular features and low suspicion of CRC in young symptomatic individuals. When confronting young-onset CRC with older patients, issues such as biological aggressiveness, stage at diagnosis and clinical outcomes seem to differ in many aspects. In the future, the identification of the molecular profile underlying the early development of sporadic CRC will help to plan tailored screening recommendations and improve management. Besides that, differential diagnosis with CRC linked with hereditary syndromes is necessary to provide adequate patient treatment and family screening. Until we find the answers to some of these doubts, doctors should raise suspicion when evaluating an young adult and be aware of this risk and consequences of a late diagnosis.
散发性结直肠癌(CRC)传统上在 60 岁以后被诊断出来,目前的监测建议仅包括年龄大于 50 岁的患者。然而,越来越多的报道显示,40 岁以下的患者 CRC 的发病率也在增加。这种情况归因于不同的分子特征和年轻有症状个体对 CRC 的低怀疑率。在面对年轻发病的 CRC 与老年患者时,在生物学侵袭性、诊断时的分期和临床结局等方面,似乎在许多方面都存在差异。在未来,对散发性 CRC 早期发展背后的分子谱的识别将有助于制定针对性的筛查建议和改善管理。此外,与遗传性综合征相关的 CRC 的鉴别诊断对于提供适当的患者治疗和家族筛查是必要的。在我们找到这些疑问的答案之前,医生在评估年轻成年人时应该提高警惕,并意识到这种风险和延迟诊断的后果。